Vyvanse 70 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FBRVH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,849
Award facts
- Contract value 100% obligated
- $3,848.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,848.78 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded on September 12, 2025, with an ultimate completion date of September 15, 2025, and represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and operates as a major pharmaceutical distributor providing critical medical procurement support to federal defense and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract structure allows AmerisourceBergen to serve various federal customers including the Defense Health Agency and U.S. Coast Guard through a flexible procurement vehicle aligned with the DLA's Pharmaceutical Prime Vendor Global Program.
Quick answers
Who was awarded contract SPE2DB25FBRVH?
SPE2DB25FBRVH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FBRVH worth?
The government has obligated $3,849 on SPE2DB25FBRVH.
Is contract SPE2DB25FBRVH an order under another contract?
Yes. SPE2DB25FBRVH is a delivery order under SPE2DB24D2011, an indefinite delivery contract.
Was contract SPE2DB25FBRVH competed?
The extent of competition for SPE2DB25FBRVH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award